| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Novo Nordisk A/S (NYSE: NVO)
NVO Technical Analysis
5
| As on 9th Jun 2023 NVO SHARE Price closed @ 158.05 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 107.43 & Strong Buy for SHORT-TERM with Stoploss of 102.27 we also expect STOCK to react on Following IMPORTANT LEVELS. |
NVOSHARE Price
| Open | 157.54 | Change | Price | % |
| High | 158.24 | 1 Day | -1.40 | -0.88 |
| Low | 156.98 | 1 Week | -2.41 | -1.50 |
| Close | 158.05 | 1 Month | -7.97 | -4.80 |
| Volume | 1180200 | 1 Year | 51.84 | 48.81 |
| 52 Week High 172.65 | 52 Week Low 93.10 | ||||
NYSE USA Most Active Stocks
| DDR | 15.44 | -4.46% |
| NIO | 7.73 | -0.77% |
| TWTR | 53.70 | 0.66% |
| CVNA | 19.07 | -21.30% |
| BACA-U | 302.00 | 0.67% |
| PLTR | 15.02 | -1.12% |
| F | 13.74 | 1.18% |
| CS | 0.89 | 1.14% |
| RPAI | 13.15 | -3.17% |
| AUY | 5.85 | -0.68% |
NYSE USA Top Gainers Stocks
NYSE USA Top Losers Stocks
| NVO Daily Charts |
NVO Intraday Charts |
Whats New @ Bazaartrend |
NVO Free Analysis |
|
|
NVO Important Levels Intraday
| RESISTANCE | 160.48 |
| RESISTANCE | 159.70 |
| RESISTANCE | 159.22 |
| RESISTANCE | 158.74 |
| SUPPORT | 157.36 |
| SUPPORT | 156.88 |
| SUPPORT | 156.40 |
| SUPPORT | 155.62 |
NVO Forecast April 2024
| 4th UP Forecast | 188.23 |
| 3rd UP Forecast | 178.55 |
| 2nd UP Forecast | 172.57 |
| 1st UP Forecast | 166.58 |
| 1st DOWN Forecast | 149.52 |
| 2nd DOWN Forecast | 143.53 |
| 3rd DOWN Forecast | 137.55 |
| 4th DOWN Forecast | 127.87 |
NVO Weekly Forecast
| 4th UP Forecast | 176.13 |
| 3rd UP Forecast | 170.33 |
| 2nd UP Forecast | 166.75 |
| 1st UP Forecast | 163.16 |
| 1st DOWN Forecast | 152.94 |
| 2nd DOWN Forecast | 149.35 |
| 3rd DOWN Forecast | 145.77 |
| 4th DOWN Forecast | 139.97 |
NVO Forecast2024
| 4th UP Forecast | 315.02 |
| 3rd UP Forecast | 264.68 |
| 2nd UP Forecast | 233.56 |
| 1st UP Forecast | 202.45 |
| 1st DOWN Forecast | 113.65 |
| 2nd DOWN Forecast | 82.54 |
| 3rd DOWN Forecast | 51.42 |
| 4th DOWN Forecast | 1.08 |
Novo Nordisk A/S ( NYSE USA Symbol : NVO )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
NVO Business Profile
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Lund University to develop treatment for Parkinson's diseases; and bluebird bio, Inc. to develop genome editing treatments for children and adult patients. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark. Address: Novo Allé 1, Bagsvaerd, Denmark, 2880
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service